Author
J. Hicks
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2024 · peak 5/yrCo-Author Collaboration Network
10 top collaborators · 16 mutual co-author links12 papers
Recent·Most cited
Cells in the Polyaneuploid Cancer Cell State are Pro-Metastatic
M. M. Mallin, L. T. A. Rolle, M. J. Schmidt, S. Priyadarsini Nair, A. J. Zurita, P. Kuhn, J. Hicks, K. J. Pienta, S. R. Amend
This study shows that polyaneuploid cancer cells (PACCs) are pro-metastatic in vivo, based on in vitro and in vivo experiments in mouse models.
bioRxiv · Jul 12, 2024 · PreprintCancer Biology
Self-Supervised Learning Improves Accuracy and Data Efficiency for IMU-Based Ground Reaction Force Estimation
T. Tan, P. Shull, J. Hicks, S. Uhlrich, A. Chaudhari
This paper uses self-supervised learning to improve accuracy and reduce data requirements for estimating ground reaction forces from IMU data.
bioRxiv · Oct 25, 2023Bioengineering
A role for the ATP-dependent DNA ligase Lig E of Neisseria gonorrhoeae in biofilm formation
J. Pan, J. Hicks, A. Williamson
This study shows that Lig E in Neisseria gonorrhoeae is non-essential for DNA repair but plays a role in biofilm formation and extracellular DNA joining.
bioRxiv · Sep 19, 2023 · PreprintMicrobiology
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
M. K. Graham, R. Wang, R. Chikarmane, B. Wodu, A. Vaghasia, A. Gupta, Q. Zheng, J. Hicks, P. Sysa-Shah, X. Pan, N. Castagna, J. Liu, J. Meyers, A. Skaist, Y. Zhang, , S. Yegnasubramanian
This study identifies MYC signaling activation as a common driver of tumor microenvironment alterations in human and murine prostate cancer through single-cell RNA-sequencing and comparative analysis.
bioRxiv · Sep 7, 2023Cancer Biology
Simulated musculoskeletal optimization for sprinting and marathon running
T. Van Wouwe, J. Hicks, S. Delp, K. Liu
This study develops a differentiable musculoskeletal simulator to optimize sprinting and marathon running performance, revealing new insights into muscle distribution and hip musculature importance.
bioRxiv · Aug 7, 2023 · PreprintBioengineering
Progressive spreading of DNA methylation in the GSTP1 promoter CpG island across transitions from precursors to invasive prostate cancer
H. Gupta, H. Inoue, Y. Nakai, M. Nakayama, T. Jones, J. Hicks, B. Kumar, M. Gurel, W. G. Nelson, A. M. De Marzo, S. Yegnasubramanian
The paper examines DNA methylation patterns in the GSTP1 promoter across prostate cancer progression stages and finds increasing methylation from normal to cancerous lesions.
Cancer Prevention Research · Aug 1, 2023Peer-reviewedCancer Biology
OpenSense: An open-source toolbox for Inertial-Measurement-Unit-based measurement of lower extremity kinematics over long durations
M. Al Borno, J. O'Day, V. Ibarra, J. Dunne, A. Seth, A. Habib, C. Ong, J. Hicks, S. Uhlrich, S. Delp
OpenSense estimates lower extremity joint kinematics from IMUs with accuracy comparable to optical motion capture and minimal drift over 10 minutes.
Journal of NeuroEngineering and Rehabilitation · Feb 20, 2022Peer-reviewedBioengineering
PHENOTYPIC CHARACTERIZATION OF TWO NOVEL CELL LINE MODELS OF CASTRATION RESISTANT PROSTATE CANCER.
M. C. Haffner, A. Bhamidipati, H. K. Tsai, D. M. Esopi, A. M. Vaghasia, J.-Y. Low, R. A. Patel, G. Guner, M.-T. Pham, N. Castagna, J. Hicks, N. Wyhs, R. Aebersold, A. M. De Marzo, W. G. Nelson, , S. Yegnasubramanian
This study develops two novel castration-resistant prostate cancer cell lines and characterizes their transcriptomic and proteomic profiles to understand resistance mechanisms.
bioRxiv · Jul 4, 2021 · PreprintCancer Biology
P2X4 Purinergic Receptors as a Therapeutic Target in Aggressive Prostate Cancer
J. P. Maynard, J. Lu, I. Vidal, J. Hicks, L. Mummert, T. Ali, R. Kempski, A. M. Carter, R. Sosa, L. B. Peiffer, C. E. Joshu, T. L. Lotan, A. M. De Marzo, K. S. Sfanos
This study identifies P2X4 purinergic receptors as a driver of aggressive prostate cancer and a potential therapeutic target through in vitro and in vivo experiments.
bioRxiv · Jun 4, 2021Cancer Biology
Discovery of A New Class of Integrin Antibodies for Fibrosis
J. Zhang, T. Wang, A. Saigal, J. Johnson, J. Morrisson, S. Tabrizifard, S. A. Hollingsworth, M. J. Eddins, W. Mao, K. O'Neill, M. Garcia-Calvo, E. Carballo-Jane, D. Liu, T. Ham, Q. Zhou, , M. Handa
The paper identifies new integrin antibodies that inhibit fibrosis progression in lung injury models and show superior in vitro activity in fibroblasts.
bioRxiv · Jul 20, 2020Pharmacology & Toxicology
A Pentatricopeptide Repeat Protein in the Plasmodium apicoplast is essential and shows sequence-specific RNA binding
J. Hicks, I. Lassadi, E. Carpenter, M. Eno, A. Vardakis, R. F. Waller, C. Howe, R. E. R. Nisbet
This study identifies and characterizes PPR1, an essential apicoplast-targeted PPR protein in Plasmodium that binds specific RNA sequences and protects transcripts from degradation.
bioRxiv · Sep 19, 2018 · PreprintMicrobiology